Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) accounts for approximately 30% of non-Hodgkin lymphoma (NHL) cases in adult series. DLBCL is characterized by marked clinical and biological heterogeneity, encompassing up to 16 distinct clinicopathological entities. While current treatments are effective in 60%...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Barca, Eva, Coronado, Mónica, Martín, Alejandro, Montalbán, Carlos, Montes-Moreno, Santiago, Panizo, Carlos, Rodríguez, Guillermo, Sancho, Juan Manuel, López-Hernández, Andrés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122355/
https://www.ncbi.nlm.nih.gov/pubmed/30190794
http://dx.doi.org/10.18632/oncotarget.25892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122355/
https://www.ncbi.nlm.nih.gov/pubmed/30190794
http://dx.doi.org/10.18632/oncotarget.25892

Ejemplares similares